Strides Shasun receives USFDA tentative approval for Roflumilast tablets
The product can be launched earliest by January 2020
Strides Shasun has announced that it has received tentative approval from the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Strides Shasun
Strides Shasun to divest UK arm for GBP 25 m
The transaction is expected to achieve closure in the second quarter of FY 17
Strides Shasun to acquire three brands of Moberg Pharma
The acquisition is for a total consideration of $10 million plus inventory value
Strides Shasun's arm Strides Pharma has entered…
Strides Shasun biotech arm receives $8.49 million investment from GMS Holdings
Further equity infusion by GMS Pharma (Singapore) will be made in tranches based on the project and product development needs over…
Sun completes sale of two Ranbaxy divisions to Strides Shasun
The agreement involved transfer of these two marketing divisions, along with employees to Strides, for Rs 165 crore
Sun…
Strides Shasun gets CCI nod to buy Sun Pharma’s two divisions
The agreement involves transfer of these two marketing divisions along with employees to Strides for a consideration of
Rs 165…
Strides Shasun receives DCG(I) nod for Sofosbuvir
The product will be marketed under the brand name ‘Virso’ in India and overseas
Strides Shasun has received approval for…
Strides Shasun opens QIP, floor price at Rs 1,344.78 per scrip
Plans to raise up to Rs 1,500 crore
Strides Shasun has opened the issue of shares of the company through qualified institutions…